Venkateswaran, Niranjan
Garcia, Roy
Lafita-Navarro, M. Carmen
Hao, Yi-Heng
Perez-Castro, Lizbeth
Nogueira, Pedro A. S.
Solmonson, Ashley
Mender, Ilgen
Kilgore, Jessica A.
Fang, Shun
Brown, Isabella N.
Li, Li
Parks, Emily http://orcid.org/0000-0002-7020-8152
Lopes dos Santos, Igor http://orcid.org/0000-0001-9199-9603
Bhaskar, Mahima
Kim, Jiwoong http://orcid.org/0000-0003-0220-9329
Jia, Yuemeng
Lemoff, Andrew http://orcid.org/0000-0002-4943-0170
Grishin, Nick V.
Kinch, Lisa
Xu, Lin http://orcid.org/0000-0001-5815-4457
Williams, Noelle S.
Shay, Jerry W. http://orcid.org/0000-0001-5052-0627
DeBerardinis, Ralph J. http://orcid.org/0000-0002-2705-7432
Zhu, Hao http://orcid.org/0000-0002-8417-9698
Conacci-Sorrell, Maralice http://orcid.org/0000-0002-4371-5087
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (NCI R01CA245548)
Article History
Received: 23 August 2022
Accepted: 9 April 2024
First Online: 20 May 2024
Competing interests
: RJD is a scientific advisor for Agios Pharmaceuticals, Nirogy Therapeutics, Vida Ventures and Droia Ventures, and a founder and advisor for Atavistik Bioscience. The remaining authors declare no other competing interests.